From The Industry Experts
-
Using Tech Enabled Solutions To Boost Productivity And Sustainability
5/1/2024
Clinical trials continue to face challenges related to cost, patient technology adoption, and resource management. Uncover how investing in suitable tech solutions can enhance efficiency and reduce companies' carbon footprint.
-
Vaccine Trial Sees >90% eCOA Adherence
5/1/2024
Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.
-
U.S. Renal Care Achieves 75% Site Adoption Of eConsent
5/1/2024
By dispelling prevalent misconceptions regarding participant age, cost, and complexity, see how this platform emerged as a versatile, rapid, and effective solution tailored to the unique needs of the elderly renal care population.
-
Experts Discuss AI’s Future In Pharma
5/1/2024
At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.
-
How Partnership Ensured A Successful First Digital Trial
5/1/2024
Discover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.
-
No Delays: How To Achieves A 99% Device Shipment Rate
5/1/2024
Boasting a 99% device shipment rate, uncover how the success stems from expert teams employing a proven model, including partnership building, customized expertise development, and proactive supply chain and technology management.
-
Shifting The Approach: 4 Strategies For ICH E6(R3) Implementation
4/30/2024
In addition to codifying some best practices, R3 suggests sponsors take a proportionate approach to identifying and managing areas of risk.
-
Early Exposure & Site Network Support Enable PI’s Enduring Interest In Research
4/30/2024
Seasoned Phase 1 principal investigator and site co-director Manish Sharma, MD, recounts his career thus far as a PI, offering insights into PI motivation, retention, and satisfaction.
-
Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression
4/30/2024
MindBio Therapeutics CEO Justin Hanka details the company’s Phase 2a clinical trial investigating the use of a take-home microdosing regimen for depression.
-
Patient And Public Involvement – Stranded On The Adoption Curve?
4/29/2024
By elucidating the barriers impeding progress on the PPI adoption curve and offering actionable insights, this article aims to catalyze renewed efforts toward harnessing the full potential of patient engagement in shaping the future of healthcare delivery.